---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-018503"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T18:05:00.148089+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics amends bylaws, removes InvaGen special rights, changes quorum

## Summary
- Board adopted Second Amended and Restated Bylaws effective February 9, 2023.
- Removed all special rights and provisions previously granted to InvaGen Pharmaceuticals Inc.
- Quorum for stockholder meetings changed to majority of outstanding voting power.
- No immediate financial or operational impact disclosed.

## SEC filing metadata
- accession: 0001104659-23-018503
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/0001104659-23-018503-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/tm236264d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-018503
- JSON: https://secwatch.observer/filing/0001104659-23-018503.json
- Plain text: https://secwatch.observer/filing/0001104659-23-018503.txt

## Key facts
- Governance Changes
  AVENUE THERAPEUTICS, INC.: Removed special rights provisions for InvaGen Pharmaceuticals and changed stockholder meeting quorum requirement to majority of outstanding voting power (effective 2023-02-09).
  - Change: bylaw amendment
  - Effective: 2023-02-09
  source text: On February 9, 2023, the Board of Directors (the “Board”) of Avenue Therapeutics, Inc. (the “Company”) adopted the Second Amended and Restated Bylaws of the Company (the “Amended Bylaws”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465923018503/0001104659-23-018503-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.